Henderson Jane
Chief Financial Officer
CIK: 1422304
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 406 | $71.66 | $29,093.96 | View Details Filing |
| Mar 2, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 300 | $68.27 | $20,481.00 | View Details Filing |
| Mar 2, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 994 | $70.45 | $70,027.30 | View Details Filing |
| Mar 2, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 300 | $69.43 | $20,829.00 | View Details Filing |
| Feb 2, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 100 | $66.89 | $6,689.00 | View Details Filing |
| Feb 2, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 1,108 | $66.15 | $73,294.20 | View Details Filing |
| Feb 2, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 792 | $65.21 | $51,646.32 | View Details Filing |
| Jan 6, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 2,000 | $80.00 | $160,000.00 | View Details Filing |
| Jan 2, 2026 | Apogee Therapeutics, Inc. (APGE) | A | 83,690 | $0.00 | $0.00 | View Details Filing |
| Jan 2, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 1,920 | $74.13 | $142,329.60 | View Details Filing |
| Jan 2, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 4,080 | $75.20 | $306,816.00 | View Details Filing |